Skip to content

Epidemiologic Study Evaluating Infections in Elderly Patients

Epidemiologic Study of Infections in Elderly Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00900952
Enrollment
240
Registered
2009-05-13
Start date
2009-03-31
Completion date
2009-06-30
Last updated
2009-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Brief summary

The purpose of this observational study is to assess the prevalence and demographic and clinical characteristics of infections in elderly people admitted to Internal Medicine wards in Spain, as well as the etiology and resistance pattern for the main causal agents, and outcome.

Interventions

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients \> 65 years of age that are hospitalized in an Internal Medicine ward and have an active infection (skin and soft tissue, intra-abdominal, or respiratory infections) from the community that needs antibiotic treatment * Patients must have at least one sample processed for microbiological diagnosis

Exclusion criteria

* COPD exacerbation * Urinary tract infections * Hospital acquired infections * Other infections not in inclusion criteria

Design outcomes

Primary

MeasureTime frame
Prevalence of each kind of infection will be measured from a descriptive point of view, using relative and absolute frequencies.5 months

Secondary

MeasureTime frame
Study the etiology and resistance pattern for the main causal agents.5 months
Describe the demographic features, co-morbidities, concomitant treatment and outcome of patients.5 months

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026